Skandinaviska Enskilda Banken (SEB)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $605K | Hold |
43,245
| – | – | ﹤0.01% | 690 |
|
|
2025
Q1 | $588K | Hold |
43,245
| – | – | ﹤0.01% | 677 |
|
|
2024
Q4 | $875K | Hold |
43,245
| – | – | ﹤0.01% | 668 |
|
|
2024
Q3 | $1.26M | Hold |
43,245
| – | – | 0.01% | 651 |
|
|
2024
Q2 | $1M | Hold |
43,245
| – | – | ﹤0.01% | 642 |
|
|
2024
Q1 | $887K | Sell |
43,245
-304,958
| -88% | -$6.26M | ﹤0.01% | 669 |
|
|
2023
Q4 | $7.47M | Hold |
348,203
| – | – | 0.04% | 314 |
|
|
2023
Q3 | $7.18M | Hold |
348,203
| – | – | 0.05% | 308 |
|
|
2023
Q2 | $10.3M | Buy |
348,203
+41,233
| +13% | +$1.22M | 0.07% | 258 |
|
|
2023
Q1 | $7.07M | Sell |
306,970
-2,122
| -0.7% | -$48.9K | 0.05% | 320 |
|
|
2022
Q4 | $8.6M | Buy |
309,092
+17,784
| +6% | +$495K | 0.06% | 273 |
|
|
2022
Q3 | $8.94M | Buy |
291,308
+78,485
| +37% | +$2.41M | 0.07% | 257 |
|
|
2022
Q2 | $6.26M | Buy |
212,823
+74,324
| +54% | +$2.19M | 0.05% | 320 |
|
|
2022
Q1 | $4.46M | Sell |
138,499
-64
| -0% | -$2.06K | 0.03% | 431 |
|
|
2021
Q4 | $6.24M | Buy |
138,563
+6,509
| +5% | +$293K | 0.03% | 375 |
|
|
2021
Q3 | $6.66M | Buy |
132,054
+102,269
| +343% | +$5.16M | 0.04% | 358 |
|
|
2021
Q2 | $2.34M | Buy |
29,785
+3,685
| +14% | +$289K | 0.01% | 621 |
|
|
2021
Q1 | $1.49M | Hold |
26,100
| – | – | 0.01% | 739 |
|
|
2020
Q4 | $2.19M | Buy |
+26,100
| New | +$2.19M | 0.02% | 618 |
|